Show simple item record

dc.contributor.authorGill, Jason H.*
dc.contributor.authorLoadman, Paul*
dc.date.accessioned2010-12-14T13:21:33Z
dc.date.available2010-12-14T13:21:33Z
dc.date.issued2008
dc.identifier.citationGill, J. H. and Loadman, Paul M. (2008). Development of tumour selective and endoprotease-activated anticancer therapeutics. In: Edwards, D., Hoyer-Hansen, G., Blasi, F. and Sloane, B. F. (Eds.). The Cancer Degradome: Proteases and Cancer Biology. London: Springer. ISBN: 978-0-387-69056-8. Chapter 40.en
dc.identifier.urihttp://hdl.handle.net/10454/4566
dc.descriptionnoen
dc.language.isoenen
dc.publisherSpringeren
dc.subjectMMPen
dc.subjectProdrugen
dc.subjectAnticancer therapeuticsen
dc.subjectAntitumor activityen
dc.subjectEndoproteaseen
dc.titleDevelopment of tumour selective and endoprotease-activated anticancer therapeutics.en
dc.status.refereedN/Aen
dc.typeBook chapteren
dc.identifier.JournalTitleISBN: 978-0-387-69056-8en
dc.identifier.doihttps://doi.org/10.1007/978-0-387-69057-5


This item appears in the following Collection(s)

Show simple item record